Trial Condition(s):

Atrial Fibrillation

Burden of ischemic stroke and intake of oral anticoagulants in patients with atrial fibrillation in the UK primary care (BEST-AF)

Bayer Identifier:

21094

ClinicalTrials.gov Identifier:

NCT04099238

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This study will characterize patients with ischemic stroke, a condition which occurs when a vessel supplying blood to the brain is obstructed, and a subpopulation of patients with irregular and often rapid heart rate (atrial fibrillation) in a UK general population using The Health Improvement Network (THIN) database.
The main aim of the study is to estimate in how many patients atrial fibrillation was diagnosed at the moment of stroke and to describe whether these patients received OAC at the time of the stroke. In addition, researchers want to learn about the relative risk of ischemic stroke when such patients did not continue OAC treatment.

Inclusion Criteria
- Occurrence of an ischemic stroke that lead to hospitalization between 01-Jul-2016 to 30-Jun-2018 and concerned adults registered in the THIN database
- Subgroup: Patients with diagnosed NVAF prior or at the time of ischemic stroke
Exclusion Criteria
- None

Trial Summary

Enrollment Goal
3739
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Unspecified
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many facilities

Many locations, United Kingdom

Status
Completed
 

Trial Design